CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

Blue Cross of Idaho

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
A
Index (ASP = 100)
107.1
Vs. acquisition
+4.3%
Brand index
106.9
Biosimilar index
113.7
Contract variability
Medium
Drugs observed
928
States
6

Contracts above the typical acquisition benchmark (102.7) on the median drug.

Thin book — treat these figures as indicative, not comparable.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.